Endurance-trained Male Cyclists Research Articles

Acute Effects of New Zealand Blackcurrant Extract on Cycling Time-Trial Are Performance Dependent in Endurance-Trained Cyclists: A Home-Based Study.

The intake of anthocyanin-rich New Zealand blackcurrant (NZBC) extract (300 mg per day) over a week enhanced 16.1 km cycling time trial (TT) performance in endurance-trained cyclists without acute performance effects. In the present study, the acute effects of an intake of 900 mg of NZBC extract 2 h before performing the 16.1 km cycling TT were examined. A total of 34 cyclists (26 males; 8 females) (age: 38 ± 7 years, V˙O2max: 57 ± 5 mL·kg-1·min-1) completed 4 16.1 km TTs (2 familiarization and 2 experimental trials) over 4 mornings on a home turbo-trainer connected with the online training simulator ZWIFT. There was no difference in time to complete the 16.1 km TT between conditions (placebo: 1422 ± 104 s; NZBC extract: 1414 ± 93 s, p = 0.07). However, when participants were split between faster (<1400 s; 1 female; 16 males) and slower (>1400 s; 7 females; 10 males) cyclists based on average familiarization TTs, a difference in TT performance was observed only in the slower group (placebo: 1499 ± 91 s; NZBC extract: 1479 ± 83 s, p = 0.02). At 12 km (quartile analysis), power output (p = 0.04) and speed (p = 0.04) were higher compared to the placebo with no effects on heart rate and cadence. The acute effects of 900 mg of NZBC extract on a 16.1 km cycling time-trial may depend on the performance ability of male endurance-trained cyclists. More work is needed to address whether there is a sex-specific time-trial effect of NZBC extract independent of performance ability.

Time to exhaustion during cycling is not well predicted by critical power calculations.

Three to 5 cycling tests to exhaustion allow prediction of time to exhaustion (TTE) at power output based on calculation of critical power (CP). We aimed to determine the accuracy of CP predictions of TTE at power outputs habitually endured by cyclists. Fourteen endurance-trained male cyclists underwent 4 randomized cycle-ergometer TTE tests at power outputs eliciting (i) mean Wingate anaerobic test (WAnTmean), (ii) maximal oxygen consumption, (iii) respiratory compensation threshold (VT2), and (iv) maximal lactate steady state (MLSS). Tests were conducted in duplicate with coefficient of variation of 5%-9%. Power outputs were 710 ± 63 W for WAnTmean, 366 ± 26 W for maximal oxygen consumption, 302 ± 31 W for VT2 and 247 ± 20 W for MLSS. Corresponding TTE were 00:29 ± 00:06, 03:23 ± 00:45, 11:29 ± 05:07, and 76:05 ± 13:53 min:s, respectively. Power output associated with CP was only 2% lower than MLSS (242 ± 19 vs. 247 ± 20 W; P < 0.001). The CP predictions overestimated TTE at WAnTmean (00:24 ± 00:10 mm:ss) and MLSS (04:41 ± 11:47 min:s), underestimated TTE at VT2 (-04:18 ± 03:20 mm:ss; P < 0.05), and correctly predicted TTE at maximal oxygen consumption. In summary, CP accurately predicts MLSS power output and TTE at maximal oxygen consumption. However, it should not be used to estimate time to exhaustion in trained cyclists at higher or lower power outputs (e.g., sprints and 40-km time trials). Novelty CP calculation enables to predict TTE at any cycling power output. We tested those predictions against measured TTE in a wide range of cycling power outputs. CP appropriately predicted TTE at maximal oxygen consumption intensity but err at higher and lower cycling power outputs.

Exercise intensity regulates the effect of heat stress on substrate oxidation rates during exercise

Hyperthermia stimulates endogenous carbohydrate metabolism during exercise; however, it is not known if exercise intensity impacts the metabolic effect of heat stress. In the first study of this two-part investigation, endurance-trained male cyclists performed incremental exercise assessments in 18 and 35°C (60% rH). The stimulatory effect of heat stress on carbohydrate oxidation rates was greater at high vs. moderate vs. low relative intensity (P < 0.05). In agreement, no effects of heat stress on carbohydrate oxidation rates were observed during 60-min of subsequent low-intensity cycling. In study two, endurance-trained male cyclists performed 20-min of moderate-intensity (power at the first ventilatory threshold) and 5-min of high-intensity (power at the second ventilatory threshold) cycling in 18, 28, 34, and 40°C (60% rH). At moderate-intensity, carbohydrate oxidation rates were significantly elevated by heat stress in 40°C (P < 0.05), whereas at high-intensity carbohydrate oxidation rates were significantly elevated by heat stress in 34 and 40°C (P < 0.05). This exercise intensity-mediated regulation of the effect of heat stress on carbohydrate oxidation may be partially attributable to observed plasma adrenaline responses. Our data suggest that under moderate environmental heat stress (34–35°C, 60% rH), heat stress-induced changes in CHO oxidation rates are unlikely to occur unless the relative exercise intensity is high (81 ± 8%⩒O2max), whereas under more extreme environmental heat stress (40°C, 60% rH), these changes occur at lower relative intensities (69 ± 8%⩒O2max). This provides indication of when heat stress-induced metabolic changes during exercise are likely to occur.

Carbohydrate hydrogel beverage provides no additional cycling performance benefit versus carbohydrate alone.

This study examined the effects of a novel maltodextrin-fructose hydrogel supplement (MF-H) on cycling performance and gastrointestinal distress symptoms. Nine endurance-trained male cyclists (age = 26.1 ± 6.6, mass = 80.9 ± 10.4kg, VO2max = 55.5 ± 3.6mL·kg·min-1) completed three experimental trials consisting of a 98-min varied-intensity cycling protocol followed by a performance test of ten consecutive sprint intervals. In a cross-over design, subjects consumed 250mL of a treatment beverage every 15min of cycling. Treatments consisted of 78g·hr-1 of either (a) MF-H, (b) isocaloric maltodextrin-fructose (ratio-matched 2:1; MF), and (c) isocaloric maltodextrin only (MD). There were no differences in average sprint power between treatments (MF-H, 284 ± 51W; MF, 281 ± 46W; and MD, 277 ± 48W), or power output for any individual sprint. Subjective ratings of gastrointestinal distress symptoms (nausea, fullness, and abdominal cramping) increased significantly over time during the cycling trials, but few individuals exceeded moderate levels in any trial with no systematic differences in gastrointestinal discomfort symptoms observed between treatments. In conclusion, ingestion of a maltodextrin/fructose hydrogel beverage during high-intensity cycling does not improve gastrointestinal comfort or performance compared to MF or MD beverages.

The Effects of Sodium Phosphate Supplementation on Physiological Responses to Submaximal Exercise and 20 km Cycling Time-Trial Performance

ABSTRACTThe aim of this study was to examine the effects of sodium phosphate (SP) supplementation on physiological responses to submaximal exercise and 20 km cycling time-trial performance. Using a randomized, double-blind, crossover design, 20 endurance-trained male cyclists (age: 31 ± 6 years; height: 1.82 ± 0.07 m; body mass: 76.3 ± 7.0 kg; maximal oxygen uptake [V̇O2max]: 57.9 ± 5.5 mL·kg−1·min−1) completed two supplementation trials separated by a 14-day washout period. The trials consisted of 10 minutes of cycling at 65% V̇O2max followed by a 20 km time trial. Expired air was monitored throughout each trial for the evaluation of V̇O2, minute ventilation (V̇E), and respiratory exchange ratio (RER). Heart rate was monitored during each trial along with ratings of perceived exertion (RPE) and blood lactate concentration. For four days before each trial, participants ingested 50 mg·kg fat-free mass−1·day−1 of either SP or placebo. There were no effects (p ≥ .05) of supplementation on physiological responses during cycling at 65% V̇O2max. There were also no effects of supplementation on time-trial performance (placebo: 32.8 ± 2.2 min; SP: 32.8 ± 2.3 min). Nevertheless, relative to placebo, SP increased V̇E (mean difference: 3.81 L·min−1; 95% confidence interval: [0.16, 7.46 L·min−1]), RER (mean difference: 0.020; 95% confidence interval: [0.004, 0.036]), and RPE (mean difference: 0.39; 95% confidence interval: [0.04, 0.73]) during time trials, as well as post time-trial blood lactate concentration (mean difference: 1.06 mmol·L−1; 95% confidence interval: [0.31, 1.80 mmol·L−1]). In conclusion, SP supplementation has no significant effects on submaximal physiological responses or 20 km time-trial performance.

Effect of dietary nitrate supplementation on thermoregulatory and cardiovascular responses to submaximal cycling in the heat.

This study investigated whether reported improvements in blood flow distribution, and the possible related effects on thermoregulation during exercise following supplementation with beetroot juice (BR), a rich source of dietary nitrate (NO3-), are mitigated in the heat. 12 male endurance-trained cyclists (age 27 ± 6years, VO2peak 68.6 ± 8.1mlkg-1min-1) completed two 60min submaximal cycling trials at 60% of VO2peak power output. Trials were performed in hot environmental conditions (33.3 ± 0.4°C, 48.8 ± 3.0% RH) following 3days of supplementation with either NO3--rich BR (6.5mmol NO3- for 2days and 13mmol NO3- on the final day) or NO3--depleted placebo (PLA). Salivary NO3- and nitrite (NO2-) were measured before and after the supplementation period. During exercise, cutaneous blood flow, blood pressure (MAP), core temperature (Tc), mean skin temperature (Tsk), indices of muscle oxygenation and oxygen (O2) consumption were measured. Salivary NO3- and NO2- increased significantly following BR by 680 and 890%, respectively. There were no significant differences observed for cutaneous blood flow, MAP, Tc, Tsk, muscle oxygenation, or O2 consumption between BR and PLA. This investigation shows that the ergogenic effects and health benefits of BR supplementation, such as augmented cutaneous blood flow, reduced MAP, increased muscle oxygenation, and improved aerobic efficiency may be attenuated when exercise is performed in hot conditions.

Respiratory Mechanical and Cardiorespiratory Consequences of Cycling with Aerobars.

Aerobars place a cyclist in a position where the trunk is flexed forward and the elbows are close to the midline of the body. This position is known to improve cycling aerodynamics and time trial race performance compared with upright cycling positions. However, the aggressive nature of this position may have important cardiorespiratory and metabolic consequences. The purpose of this investigation was to examine the respiratory mechanical, ventilatory, metabolic, and sensory consequences of cycling while using aerobars during laboratory-based cycling. Eleven endurance-trained male cyclists (age, 26 ± 9 yr; V˙O2peak, 55 ± 5 mL·kg·min) were recruited. Visit 1 consisted of an incremental cycling test to determine peak power output. Visit 2 consisted of 6-min bouts of constant load cycling at 70% of peak incremental power output in the aerobar position, drop position, and upright position while grasping the brake hoods. Metabolic and ventilatory responses were measured using a commercially available metabolic cart, and respiratory pressures were measured using an esophageal catheter. Cycling in the aerobar position significantly increased the work of breathing (Wb), power of breathing (Pb), minute ventilation, ventilatory equivalent for oxygen and carbon dioxide, and transdiaphragmatic pressure compared with the upright position. Increases in the Wb and Pb in the aerobars relative to the upright position were strongly correlated with the degree of thoracic restriction, measured as the shoulder-to-aerobar width ratio (Wb: r = 0.80, P = 0.01; Pb: r = 0.69, P = 0.04). Aerobars significantly increase the mechanical cost of breathing and leads to greater ventilatory inefficiency compared with upright cycling. Future work is needed to optimize aerobar width to minimize the respiratory mechanical consequences while optimizing aerodynamics.

Dispelling the myth that habitual caffeine consumption influences the performance response to acute caffeine supplementation.

This study investigates the influence of habitual caffeine intake on aerobic exercise-performance responses to acute caffeine supplementation. A double-blind, crossover, counterbalanced study was performed. Forty male endurance-trained cyclists were allocated into tertiles, according to their daily caffeine intake: low (58 ± 29 mg/d), moderate (143 ± 25 mg/d), and high (351 ± 139 mg/d) consumers. Participants completed three trials in which they performed simulated cycling time trials (TTs) in the fastest time possible following ingestion of the following: caffeine (CAF: 6 mg/kg body mass), placebo (PLA), and no supplement (CON). A mixed-model analysis revealed that TT performance was significantly improved in CAF compared with PLA and CON (29.92 ± 2.18 vs. 30.81 ± 2.67 and 31.14 ± 2.71 min, respectively; P = 0.0002). Analysis of covariance revealed no influence of habitual caffeine intake as a covariate on exercise performance (P = 0.47). TT performance was not significantly different among tertiles (P = 0.75). No correlation was observed between habitual caffeine intake and absolute changes (CAF - CON) in TT performance with caffeine (P = 0.524). Individual analysis showed that eight, seven, and five individuals improved above the variation of the test in CAF in the low, moderate, and high tertiles, respectively. A Fisher's exact test did not show any significant differences in the number of individuals who improved in CAF among the tertiles (P > 0.05). Blood lactate and ratings of perceived exertion were not different between trials and tertiles (P > 0.05). Performance effects of acute caffeine supplementation during an ~30-min cycling TT performance were not influenced by the level of habitual caffeine consumption.NEW & NOTEWORTHY There has been a long-standing paradigm that habitual caffeine intake may influence the ergogenicity of caffeine supplementation. Low, moderate, and high caffeine consumers showed similar absolute and relative improvements in cycling time-trial performance following acute supplementation of 6 mg/kg body mass caffeine. Performance effects of acute caffeine were not influenced by the level of habitual caffeine consumption, suggesting that high habitual caffeine intake does not negate the benefits of acute caffeine supplementation.

Dose effects of New Zealand blackcurrant on substrate oxidation and physiological responses during prolonged cycling.

It has been previously shown that New Zealand blackcurrant (NZBC) extract increased fat oxidation during short duration cycling. The present study examined the effect of different doses of NZBC extract on substrate oxidation and physiological responses during prolonged cycling. Using a randomized counterbalanced Latin-square design, 15 endurance-trained male cyclists (age: 38±12years, height: 187±5cm, body mass: 76±10kg, [Formula: see text]: 56±8mLkg-1min-1, and mean±SD) completed four separate 120-min cycling bouts at 65% [Formula: see text] after ingesting no dose, or one of three doses (300, 600, or 900mgday-1) of NZBC extract (CurraNZ™) for 7 days. A dose effect (P<0.05) was observed for average fat oxidation (0, 300, 600, and 900mgday-1 values of 0.63±0.21, 0.70±0.17, 0.73±0.19, and 0.73±0.14gmin-1) and carbohydrate oxidation (0, 300, 600, and 900mgday-1 values of 1.78±0.51, 1.65±0.48, 1.57±0.44, and 1.56±0.50gmin-1). The individual percentage change of mean fat oxidation was 21.5 and 24.1% for 600 and 900mgday-1 NZBC extract, respectively, compared to no dose. Heart rate, [Formula: see text], [Formula: see text], plasma lactate, and glucose were not affected. Seven-day intake of New Zealand blackcurrant extract demonstrated a dose-dependent effect on increasing fat oxidation during 120-min cycling at 65% [Formula: see text] in endurance-trained male cyclists.

Effects of nitrate supplementation in trained and untrained muscle are modest with initial high plasma nitrite levels.

Nitrate (NO3-) supplementation resulting in higher plasma nitrite (NO2-) is reported to lower resting mean arterial blood pressure (MAP) and oxygen uptake (VO2 ) during submaximal exercise in non-athletic populations, whereas effects in general are absent in endurance-trained individuals. To test whether physiologic effects of NO3- supplementation depend on local muscular training status or cardiovascular fitness, male endurance-trained cyclists (CYC, n=9, VO2 -max: 64±3mL/min/kg; mean±SD) and recreational active subjects serving as a control group (CON, n=8, 46±3mL/min/kg), acutely consumed nitrate-rich beetroot juice ([NO3-] ~9mmol) (NIT) or placebo (PLA) with assessment of resting MAP and energy expenditure during moderate intensity (~50% VO2 -max) and incremental leg cycling (LEG-ex) and arm-cranking exercise (ARM-ex). NIT increased (P<.001) resting plasma NO3- by ~1200% relative to PLA. Plasma NO2- increased ~25% (P<.01) with a significant change only in CYC. LEG-ex VO2 (~2.60L/min), ARM-ex VO2 (~1.14L/min), and resting MAP (~87mm Hg) remained unchanged for CYC, and similarly for CON, no changes were observed for LEG-ex VO2 (~2.03L/min), ARM-ex VO2 (~1.06L/min), or resting MAP (~85mm Hg). VO2 -max was not affected by supplementation, but incremental test peak power was higher (P<.05) in LEG-ex for CYC in NIT relative to PLA (418±47 vs 407±46W). In both CYC and CON, high initial baseline values and small increases in plasma NO2- after NIT may have lowered the effect of the intervention implying that muscular and cardiovascular training status is likely not the only factors that influence the physiologic effects of NO3- supplementation.

Time-course of neuromuscular parameters, muscle soreness and sympatho-vagal balance following a 130-km cycling race

This article is free to read on the publishers website This study aimed identifying the effects of a 130-km cycling race on indices of physiological recovery markers of during a 72-h period. Thirteen endurance trained male cyclists underwent a collection of indices for measuring neuromuscular parameters, muscle soreness and heart rate variability at five different moments of data collections: before, after and at 24, 48 and 72-h following a cycling race. Results indicate that the neuromuscular parameters scores decreased after the race (maximal voluntary isometric contraction: 13.61%, p .05) while other neuromuscular parameters values remained lower throughout the 72-h recover period (electromyography: 10.62%, p .05). The heart rate variability values increased after the race and remained higher for 72-h afterwards (p < .05). These findings show that a 130-km cycling race has a noteworthy effect on indices of neuromuscular parameters, muscle soreness and heart rate variability responses. Moreover, these results suggest that a 72-h recovery period does not appear to be enough for long-distance cyclist and reinforce the propositions within scientific literature concerning athletes involved in endurance cycling need for a sufficient recovery period.

Cardiovascular function during supine rest in endurance-trained males with New Zealand blackcurrant: a dose-response study.

Blackcurrant contains anthocyanins that could alter cardiovascular function and reduce cardiovascular disease risk. We examined dose responses of New Zealand blackcurrant (NZBC) extract on cardiovascular function during supine rest. Fifteen endurance-trained male cyclists (age: 38±12years, height: 178±5cm, body mass: 76±10kg, [Formula: see text]: 56±8mLkg-1min-1, mean±SD) were randomly assigned using a counterbalanced Latin square design to complete four conditions, a control of no NZBC, or one of three doses (300, 600 or 900mgday-1) of NZBC extract (CurraNZ™) for 7-days with a 14-day washout. Cardiovascular function (i.e., blood pressure, heart rate, ejection time, cardiac output, stroke volume, and total peripheral resistance) during supine rest was examined (Portapres® Model 2). Systolic and diastolic blood pressure, heart rate and ejection time were unchanged by NZBC. A dose effect (P<0.05) was observed for cardiac output, stroke volume, and total peripheral resistance. A trend for a dose effect was observed for mean arterial blood pressure. Cardiac output increased by 0.6±0.6 Lmin-1 (15%) and 1.0±1.0 Lmin-1 (28%) and stroke volume by 5±8mL (7%) and 6±17mL (18%) between control and 600, and 900mgday-1, respectively. Total peripheral resistance decreased by 4±3mmHgL-1min-1 (20%) and 5±9mmHgL-1min-1 (20%) for 600, and 900mgday-1. Seven-days intake of New Zealand blackcurrant extract demonstrated dose-dependent changes on some cardiovascular parameters during supine rest in endurance-trained male cyclists.

Time-course of changes in indirect markers of muscle damage responses following a 130-km cycling race

DOI: http://dx.doi.org/10.5007/1980-0037.2016v18n3p322 The purpose of the present investigation was to identify the effects of a 130-km cycling race on indices of biochemical indirect markers of muscle damage and muscle soreness responses during a 72-hour recovery period. Fifteen endurance-trained male cyclists which were competing for more than 2 years and were involved in systematic training at least of 3 days/wk underwent a collection of indirect biochemical markers of muscle damage (CK, LDH, Myo) and delayed onset of muscle soreness (DOMS), at five different moments of data collection: before (PRE) and immediately after (POST) a 130-km cycling race, and 24, 48, 72 hours following the cycling race. CK and LDH plasma concentrations significantly increased POST-race (p &lt; 0.001) and remained high throughout the 72 hour recover period (CK: p &lt; 0.05; LDH: p &lt; 0.001). Myo increased significantly POST-race (p &lt; 0.001) and returned to the PRE-race values 24 hours thereafter (p &lt; 0.05). DOMS increased significantly POST-race (p &lt; 0.001) and returned to the PRE-race values at 48 hours after (p &gt; 0.05). A 130-km cycling race has a noteworty effect on indices of biochemical indirect markers of muscle damage and muscle soreness responses, indicating that 72 hour recovery period do not seems to be enough for long-distance cyclist, and reinforce the propositions of scientific literature about the need of a sufficient recovery period for cycling endurance athletes.

Influence of pacing on reliability of middle-distance cycling performance

The purpose of the present study was to examine the reliability of middle distance cycling time trials using fast-, even-, and slow-starts . Eighteen endurance-trained male cyclists [mean ± standard deviation; VO 2peak 63.1 ± 6.1 mL ⋅ kg -1 ⋅ min -1 ] performed nine cycling time trials where the total external work (96.5 ± 11.2 kJ) was identical to the better of two, 5-minute habituation time trials. Power output during the first quarter of the time-trials (24.1 ± 2.8 kJ) was fixed to induce fast-, even- or slow-starting strategies (60, 75 and 90 s, respectively). In consecutive sessions, participants performed three trials of each pacing condition although the order of these pacing conditions was counterbalanced. Average power output and performance time were unaffected by trial number in the fast- (P = 0.60), even- (P = 0.18) and slow-start (P = 0.53) trials. In all three pacing conditions, average power output was highly reliable and similar between trial 1 to 2 and trial 2 to 3 in fast- (standard error of measurement; SEM=8.3 and 8.2W), even (coefficient of variation; CV=2.8 and 2.4%) and slow-start (CV=2.4 and 1.5%) trials. In conclusion, the reproducibility of 5-min cycling time trials is unaffected by starting strategy and is acceptable following two self- paced habituation trials. Research examining the influence of pacing strategies may therefore be conducted without the need for familiarisation trials using each individual pacing condition.

The effect of low- vs high-cadence interval training on the freely chosen cadence and performance in endurance-trained cyclists.

The aim of this study was to determine the effects of high- and low-cadence interval training on the freely chosen cadence (FCC) and performance in endurance-trained cyclists. Sixteen male endurance-trained cyclists completed a series of submaximal rides at 60% maximal power (Wmax) at cadences of 50, 70, 90, and 110 r·min(-1), and their FCC to determine their preferred cadence, gross efficiency (GE), rating of perceived exertion, and crank torque profile. Performance was measured via a 15-min time trial, which was preloaded with a cycle at 60% Wmax. Following the testing, the participants were randomly assigned to a high-cadence (HC) (20% above FCC) or a low-cadence (LC) (20% below FCC) group for 18 interval-based training sessions over 6 weeks. The HC group increased their FCC from 92 to 101 r·min(-1) after the intervention (p = 0.01), whereas the LC group remained unchanged (93 r·min(-1)). GE increased from 22.7% to 23.6% in the HC group at 90 r·min(-1) (p = 0.05), from 20.0% to 20.9% at 110 r·min(-1) (p = 0.05), and from 22.8% to 23.2% at their FCC. Both groups significantly increased their total distance and average power output following training, with the LC group recording a superior performance measure. There were minimal changes to the crank torque profile in both groups following training. This study demonstrated that the FCC can be altered with HC interval training and that the determinants of the optimal cycling cadence are multifactorial and not completely understood. Furthermore, LC interval training may significantly improve time-trial results of short duration as a result of an increase in strength development or possible neuromuscular adaptations.

Effects of high-intensity intermittent priming on physiology and cycling performance

The pre-event warm-up or “priming” routine for optimising cycling performance is not well-defined or uniform to a specific event. We aimed to determine the effects of varying the intensity of priming on 3 km cycling performance. Ten endurance-trained male cyclists completed four 3 km time-trials (TT) on four separate occasions, each preceded by a different priming strategy including “self-selected” priming and three intermittent priming strategies incorporating 10 min of constant-load cycling followed by 5 × 10 s bouts of varying relative intensity (100% and 150% of peak aerobic power, Wpeak, and all-out priming). The self-selected priming trial (379 ± 44 W) resulted in similar mean power during the 3 km TT to intermittent priming at 100% (376 ± 45 W; −0.7%; unclear) and 150% (374 ± 48 W; −1.5%, unclear) of Wpeak, but significantly greater than all-out priming (357 ± 45 W; −5.8%, almost certainly harmful). Differences between intermittent and self-selected priming existed with regards to heart rate (6.2% to 11.5%), blood lactate (−22.9% to 125%) and VO2 kinetics (−22.9% to 8.2%), but these were not related to performance outcomes. In conclusion, prescribed intermittent priming strategies varying in intensity did not substantially improve 3 km TT performance compared to self-selected priming.

Influence of lipolysis and fatty acid availability on fuel selection during exercise

The aim of the present study was to investigate the influence of substrate availability on fuel selection during exercise. Eight endurance-trained male cyclists performed 90-min exercise at 70% of their maximal oxygen uptake in a cross-over design, either in rested condition (CON) or the day after 2-h exercise practised at 70% of maximal oxygen uptake (EX). Subjects were given a sucrose load (0.75 g kg(-1) body weight) 45 min after the beginning of the 90-min exercise test. Lipolysis was measured in subcutaneous abdominal adipose tissue (SCAT) by microdialysis and substrate oxidation by indirect calorimetry. Lipid oxidation increased during exercise and tended to decrease during sucrose ingestion in both conditions. Lipid oxidation was higher during the whole experimental period in the EX group (p = 0.004). Interestingly, fuel selection, assessed by the change in respiratory exchange ratio (RER), was increased in the EX session (p = 0.002). This was paralleled by a higher rate of SCAT lipolysis reflected by dialysate glycerol, plasma glycerol, and fatty acids (FA) levels (p < 0.001). Of note, we observed a significant relationship between whole-body fat oxidation and dialysate glycerol in both sessions (r (2) = 0.33, p = 0.02). In conclusion, this study highlights the limiting role of lipolysis and plasma FA availability to whole-body fat oxidation during exercise in endurance-trained subjects. This study shows that adipose tissue lipolysis is a determinant of fuel selection during exercise in healthy subjects.

Central and Peripheral Fatigue during Passive and Exercise-Induced Hyperthermia

Hyperthermia was induced during prolonged exercise (ExH) and passive heating (PaH) to isolate the influence of exercise on neuromuscular function during a maximal voluntary isometric contraction (MVC) of the quadriceps under heat stress. The influence of cardiovascular strain in limiting endurance performance in the heat was also examined. On separate days, eight males cycled to exhaustion at 60% maximal oxygen uptake or were immersed in a water bath (∼41°C) until rectal temperature (Tre) increased to 39.5°C. The ExH and PaH interventions were performed in ambient conditions of 38°C and 60% relative humidity with Tre reaching 39.8°C during exercise. Before (control) and after each intervention, voluntary activation and force production capacity were evaluated by superimposing an electrically stimulated tetanus during a 45-s MVC. Force production decreased immediately after PaH and ExH compared with control, with the magnitude of decline being more pronounced after ExH (P < 0.01). Mean voluntary activation was also significantly depressed after both interventions (P < 0.01 vs control). However, the extent of decline in voluntary activation was maintained at ∼90% during both PaH and ExH MVC. This decline accounted for 41.5% (PaH) and 33.1% (ExH) of the decrease in force production. In addition, exhaustion coincided with a marked increase in HR (∼96% of maximum) and a decline in stroke volume (25%) and mean arterial pressure (10%) (P < 0.05). The loss of force production capacity during hyperthermia originated from central and peripheral fatigue factors, with the combination of heat stress and previous contractile activity exacerbating the rate of decline. Thus, the observed significant rise in thermal strain in ExH and PaH impaired neuromuscular function and was associated with an exercise performance limiting increase in cardiovascular strain.

Caffeine ingestion, affect and perceived exertion during prolonged cycling

Caffeine's metabolic and performance effects have been widely reported. However, caffeine's effects on affective states during prolonged exercise are unknown. Therefore, this was examined in the present study. Following an overnight fast and in a randomised, double-blind, counterbalanced design, twelve endurance trained male cyclists performed 90 min of exercise at 70% VO 2 max 1 h after ingesting 6 mg kg −1BM of caffeine (CAF) or placebo (PLA). Dimensions of affect and perceived exertion were assessed at regular intervals. During exercise, pleasure ratings were better maintained ( F (3,38) = 4.99, P < 0.05) in the CAF trial compared to the PLA trial with significantly higher ratings at 15, 30 and 75 min (all P < 0.05). Perceived exertion increased ( F (3,28) = 19.86, P < 0.01) throughout exercise and values, overall, were significantly lower ( F (1,11) = 9.26, P < 0.05) in the CAF trial compared to the PLA trial. Perceived arousal was elevated during exercise but did not differ between trials. Overall, the results suggest that a moderate dose of CAF ingested 1 h prior to exercise maintains a more positive subjective experience during prolonged cycling. This observation may partially explain caffeine's ergogenic effects.

Effect of a High and Low Dose of Caffeine on Antigen-Stimulated Activation of Human Natural Killer Cells After Prolonged Cycling

This study investigated the effect of a high and low dose of caffeine on antigen-stimulated natural killer (NK) cell (CD3- CD56+) activation after prolonged, strenuous cycling, as assessed by the early-activation molecule CD69. In a randomized crossover design, 12 healthy male endurance-trained cyclists cycled for 90 min at 70% VO2peak 60 min after ingesting either 0 (PLA), 2 (2CAF), or 6 (6CAF) mg/kg body mass of caffeine. Whole blood was stimulated with Pediacel (5 in 1) vaccine. A high dose of caffeine (6CAF) increased the number of CD3-CD56+ cells in the circulation immediately postexercise compared with PLA (p < .05). For both 2CAF and 6CAF, the geometric mean fluorescence intensity (GMFI) of CD69+ expression on unstimulated CD3-CD56+ cells was significantly higher than with PLA (both p < .05). When cells were stimulated with antigen, the GMFI of CD69 expression remained significantly higher with 2CAF than with PLA 1 hr postexercise (p < .05). Although not achieving statistical significance, 6CAF also followed a similar trend when stimulated (p = .09). There were no differences in GMFI of CD69 expression between 2CAF and 6CAF. These results suggest that a high (6 mg/kg) dose of caffeine was associated with the recruitment of NK cells into the circulation and that both a high and low (2 mg/kg) dose of caffeine increased unstimulated and antigen-stimulated NK-cell activation 1 hr after high-intensity exercise. Furthermore, there does not appear to be a dose-dependent effect of caffeine on NK-cell activation 1 hr after prolonged intensive cycling.